Sponsor Pipeline

BrightGene Bio-Medical Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
12
Active Trials
11
Recruiting
4
Phase 3
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-04 NCT07743983 A Study of BGM0504 in Early T2DM With Obesity Phase 3 Recruiting
Active Trials by Phase
Phase 3
4
Phase 2
2
Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06716203 A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and… Type 2 Diabetes Mellitus (T2DM) Recruiting
NCT06716216 A Study of BGM0504 in Participants with Type 2 Diabetes Type 2 Diabetes Mellitus (T2DM) Recruiting
NCT07064486 A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia Type 2 Diabetes (T2DM) Recruiting
NCT07743983 A Study of BGM0504 in Early T2DM With Obesity Type 2 Diabetes (T2DM) Recruiting
Phase 2
NCT06911203 A Study of BGM0504 in Participants With Obesity Obesity Recruiting
NCT07658560 A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese… Overweight or Obese Participants Without Diabetes Not Yet Recruiting
Phase 1
NCT07166081 Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504… Non-diabetic Overweight or Obese Recruiting
NCT07224399 Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812… Healhty Recruiting
NCT07239973 A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese… Healthy Recruiting
NCT07294235 A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese… Overweight or Obesity Recruiting
NCT07382908 Bioequivalence Study of BGM0504 Injection Overweight/Obesity Recruiting
NCT07566572 A Study of BGM0504 Tablets in Healthy Chinese Subjects Chinese Healthy Volunteers Recruiting
Disease Areas
Get alerts when BrightGene Bio-Medical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free